OpenCitations
Works that cite this article, indexed by OpenCitations.
Naringenin: A potential anticancer drug
Results in Chemistry 16 (2025)
Yi Zhang; Haixin Ding; Xue Zhao; Yutong Li; Pengling Ge
PRDX1 depletion predisposes to ferroptosis through inhibiting the cAMP pathway in B-cell acute lymphoblastic leukemia
Cancer Gene Therapy 33(5) (2025)
FangFang Zhong; Yan Zeng; Jing Liu; Qulian Guo; Ping Wen
Comprehensive analysis of PDE2A: a novel biomarker for prognostic value and immunotherapeutic potential in human cancers
Brazilian Journal of Medical and Biological Research 57 (2024)
Zhen Yu; Yawen Song; Jin Wang; Yujing Wu; Hefang Wang; Shuye Liu; Yu Zhu
Cyclic nucleotide phosphodiesterases as drug targets
Pharmacological Reviews 77(3) (2025)
Michy P. Kelly; Viacheslav O. Nikolaev; Leila Gobejishvili; Claire Lugnier; Christian Hesslinger; Peter Nickolaus; David A. Kass; Walma Pereira de Vasconcelos; Rodolphe Fischmeister; Stefan Brocke; Paul M. Epstein; Gary A. Piazza; Adam B. Keeton; Gang Zhou; Mohammad Abdel-Halim; Ashraf H. Abadi; George S. Baillie; Mark A. Giembycz; Graeme Bolger; Gretchen Snyder; Kjetil Tasken; Nathaniel E.B. Saidu; Martina Schmidt; Manuela Zaccolo; Ralph T. Schermuly; Hengming Ke; Rick H. Cote; Soroush Mohammadi Jouabadi; Anton J.M. Roks
NOS2 and COX-2 Co-Expression Promotes Cancer Progression: A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer
International Journal of Molecular Sciences 25(11) (2024)
Leandro L. Coutinho; Elise L. Femino; Ana L. Gonzalez; Rebecca L. Moffat; William F. Heinz; Robert Y. S. Cheng; Stephen J. Lockett; M. Cristina Rangel; Lisa A. Ridnour; David A. Wink